Trial Profile
High-dose daptomycin compared with linezolid in patients with vancomycin-resistant enterococcal (VRE) bloodstream infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary) ; Linezolid
- Indications Bacteraemia; Vancomycin-resistant enterococcal infections
- Focus Therapeutic Use
- 21 Oct 2015 New trial record
- 19 Sep 2015 Results presented at Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.